Ravi Kumar, Alimuddin Saifi, Parveen Kumar
Ravi Kumar1*, Dr. Alimuddin Saifi2, Mr. Parveen Kumar3
1Master of Pharmacy (Pharmacology), Department of Pharmacy, Bharat Institute of Technology, Meerut, 250103, Uttar Pradesh, India.
2Katyayani College of Education, Meerut (U.P.) India.
3National Chemical Laboratory, Pune (Maharashtra) India.
Volume - 13,
Issue - 1,
Year - 2021
Panic disorder is a type of anxiety disorder, in which the person feels of terror and agoraphobic situation. The panic attack is producing intense fear that begins suddenly and stays about 10-20 minutes. It is an onset attack and in patients may develop severe headache and you may feel as if you are losing control. In this article, suggest some important medicinal plants that are used in the treatment of panic disorders. The selection of best medicine is based on its side effect profile. The placebo and some therapy like as- Cognitive Behavioural Therapy (CBT) are used for the treatment of panic attack and some Ayurvedic medicines (like as- Jyotishmati, Shankapushpi, Brahmi, Ashwagandha and Bhringaraja) are reduce the symptoms of mentally disorder.
Cite this article:
Ravi Kumar, Alimuddin Saifi, Parveen Kumar. Ayurvedic Treatment of Panic Disorder. Res. J. Pharmacology and Pharmacodynamics.2021; 13(1):17-21. doi: 10.5958/2321-5836.2021.00004.5
Ravi Kumar, Alimuddin Saifi, Parveen Kumar. Ayurvedic Treatment of Panic Disorder. Res. J. Pharmacology and Pharmacodynamics.2021; 13(1):17-21. doi: 10.5958/2321-5836.2021.00004.5 Available on: https://rjppd.org/AbstractView.aspx?PID=2021-13-1-4
1. Panic Disorder. Info sheets 2013 www.heretohelp.bc.ca.
2. Panic Disorder: When Fear Overwhelms. National Institute of Mental Health.
3. Dresler T., Guhn A., Tupak S.V. New dimensions of the neuroanatomical hypothesis of panic disorder. J Neural Transm. 2013; 120(1): 3-29.
4. Types of Anxiety: Panic. Danielle’s Story.
5. Shiri M., Akhavan S. and Geramian N., Isfahan University of Medical Sciences, Isfahan, Iran. www.intechopen.com.
6. Andrews G, Crino R, Hunt C, Lampe L. Anxiety and Panic Disorder. New York: Cambridge University Press (1994).
7. Roy-Byrne P.P., Stein M.B., Russo J., Mercier E., Thomas R., McQuaid J. Panic disorder in the primary care setting: comorbidity, disability, service utilization, and treatment. J Clin Psychiatry 1999; 60:492-499.
8. Woodman, C. L., The natural history of generalized anxiety disorder: A review. Retrieved from Medscape Psychiatry and Mental Health eJournal: 1997.
9. Panic Attacks Ver3.0 – July 2013. Information from your Patient Aligned Care Team.
10. Amy B., Locke, N. Kirst, Cameron G. Shultz, American Academy of Family Physicians. 2015, Volume 91, Number 9 May 1.
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
12. Panic Disorder (panic disorder with or without agoraphobia, DSM-IV-TR 300.01, 300.21).
13. Sahib S. Khalsa, Michael E. Cameron, Schiffman J. Current Diagnosis and Treatment of Anxiety Disorders, P&T January 2013. Vol. 38 No.1.
14. Dresler T, Guhn A, Tupak S.V. New dimensions of the neuroanatomical hypothesis of panic disorder. J Neural Transm. 2013; 120(1): 3-29.
15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
16. Panic Disorder: When Fear Overwhelms. National Institute of Mental Health.
17. Peter Ham, David B. Waters, Norman Oliver M. Treatment of Panic Disorder, American Family Physician, 2005, Volume 71, Number 4 February 15.
18. Dhawan K, Kumar R, Kumar S, Sharma A: Correct Identification of Passiflora incarnate Linn. A Promising Herbal Anxiolytic and Sedative. J Med Food 2001, 4:137-144.
19. Dhawan K., Kumar S., Sharma A.: Anti-anxiety studies on extracts of Passiflora incarnata Linneaus. J Ethnopharmacol 2001, 78:165-170.
20. Akhondzadeh S., Naghavi H.R., Vazirian M., Shayeganpour A., Rashidi H., Khani M. Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther 2001, 26:363-367.
21. Bourin M, Bougerol T, Guitton B, Broutin E: A combination of plant extracts in the treatment of outpatients with adjustment disorder with anxious mood: controlled study versus placebo. Fundamental 1997, 11:127-132.
22. Movafegh A, Alizadeh R, Hajimohamadi F, Esfehani F, Nejatfar M: Preoperative oral Passiflora incarnata reduces anxiety in ambulatory surgery patients: a double-blind, placebo-controlled study. Anesth Analg 2008, 106:1728-1732.
23. Dhawan K, Kumar S, Sharma A: Comparative anxiolytic activity profile of various preparations of Passiflora incarnata linneaus: a comment on medicinal plants’ standardization. J Altern Complement Med 2002, 8:283-291.
24. Rao B.V., Bettadapura N. Srikumar, Byrathnahalli S. Rao S. Herbal Remedies to Treat Anxiety Disorders. https:// www.researchgate.net/publication/221916219.
25. Lakhan S.E., Vieira K.F., Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review. Lakhan and Vieira Nutrition Journal 2010, 9:42.
26. Volz H.P., Kieser M. Kava-kava extract WS 1490 versus placebo in anxiety disorders--a randomized placebo-controlled 25-week outpatient trial. Pharmacopsychiatry, 1997.30: 1-5.
27. Akhondzadeh S, Naghavi H.R., Vazirian M., Shayeganpour A., Rashidi H., Khani M. Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther 2001, 26:363-367.
28. Singh Y.N., Singh N.N. Therapeutic potential of kava in the treatment of anxiety disorders. CNS Drugs 2002, 16:731-743.
29. Dinh L.D., Simmen U., Bueter K.B., Bueter B., Lundstrom K., Schaffner W. Interaction of various Piper methysticum cultivars with CNS receptors in vitro. Planta Med 2001, 67:306-311.
30. Donath F, Quispe S, Diefenbach K, Maurer A, Fietze I and Roots I. Critical evaluation of the effect of valerian extracts on sleeps structure and sleep quality. Pharmacopsychiatry, 2000, 33: 47-53.
31. Benke D, Barberis A, Kopp S, Altmann KH, Schubiger M, Vogt KE, Rudolph U and Mohler H. (2009). GABA A receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts. Neuropharmacology, 2009, 56: 174-181.
32. Stevinson C. Ernst E. Valerian for insomnia: a systematic review of randomized clinical trials. Sleep Medicine 2001: 91-99.
33. Avallone R., Zanoli P., Puia G., Kleinschnitz M., Schreier P. Baraldi M. Pharmacological profile of apigenin, a flavonoid isolated from Matricaria chamomilla. Biochemical Pharmacology 59: 1387-1394.
34. Kuppusamy U.R., Das N.P., Effects of flavonoids on cyclic AMP phosphodiesterase and lipid mobilization in rat adipocytes. Biochemical Pharmacology 1992, 44: 1307-1315.
35. Chen S.W., Wang W.J., Li W.J., Wang R., Li Y.L., Huang Y.N., Liang X. Anxiolytic-like effect of asiaticoside in mice. Pharmacology Biochemistry and Behavior 2006, 85: 339-344.
36. Wijeweera P., Arnason J.T., Koszycki D. Merali Z. Evaluation of anxiolytic properties of Gotukola (Centella asiatica) extracts and asiaticoside in rat behavioral models. Phytomedicine 2006, 13: 668-676.
37. Bradwejn J, Zhou Y, Koszycki D and Shlik J. A double-blind, placebo-controlled study on the effects of Gotu Kola (Centella asiatica) on acoustic startle response in healthy subjects. Journal of Clinical Psychopharmacology 2000, 20: 680-684.
38. Jana U., Sur T.K., Maity L.N., Debnath P.K., Bhattacharyya D. A clinical study on the management of generalized anxiety disorder with Centella asiatica. Nepal Medical College Journal 2010, 12: 8-11.
39. Mishra L.C., Singh B.B., Dagenais S. (Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Alternative Medicine Review 5: 2000, 334-346.
40. Bhattacharya S.K., Muruganandam A.V., Adaptogenic activity of Withania somnifera: an experimental study using a rat model of chronic stress. Pharmacology Biochemistry and Behavior 75, 2003: 547-555.
41. Kulkarni S.K., Verma A.V., GABA receptor mediated anticonvulsant action of Withania somnifera root extract. Indian Drugs 30: 1993, 305–312.
42. Seely D and Singh R. Adaptogenic potential of a polyherbal natural health product: report on a longitudinal clinical trial. Evidence Based Complementary Alternative Medicine 4: 2007, 375-380.
43. Nanjappa K.N., Shalam Md., Harish M.S., Prabhu B.M., Shankaranarayana Rao B.S. Kutty B.M. Pharmacological and neurobiochemical evidence for antidepressant-like effect of Sumind - An herbal product in animals. The Internet Journal of Nutrition and Wellness 2007.
44. Sharma A.K., Agrawal A., Agrawal U., Dubey G.P., Influence of mentat on memory and mental fatigue in cases of anxiety neurosis and depression. Indian. Journal of Cancer and Biology Research 1990, 3: 27-30.
45. Bourin M, Bougerol T, Guitton B., Broutin E. A combination of plant extracts in the treatment of outpatients with adjustment disorder with anxious mood: controlled study versus placebo. Fundamental and Clinical Pharmacology 1997, 11: 127-132.
46. Christmas D., Hood S., Nutt D.: Potential novel anxiolytic drugs. Curr Pharm Des 2008, 14:3534-3546.
47. Smriga M., Torii K., L-Lysine acts like a partial serotonin receptor 4 antagonist and inhibits serotonin-mediated intestinal pathologies and anxiety in rats. Proc Natl Acad Sci USA 2003, 100:15370-15375.
48. Poleszak E, Szewczyk B, Kedzierska E, Wlaz P, Pilc A, Nowak G: Antidepressant- and an xiolytic-like activity of magnesium in mice. Pharmacol Biochem Behav 2004, 78:7-12.
49. Shaheen E Lakhan, Karen F Vieira, Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review. Lakhan and Vieira Nutrition Journal 2010, 9:42.